Quan Zhang

发表

Quan Zhang, Shucai Zhang, 2017, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Expression of ERCC1 and Class III β-Tubulin in Resected Non-Small Cell Lung Cancer and its Correlation with Platinum-Based Adjuvant Chemotherapy

Quan Zhang, Shucai Zhang, Qunhui Wang, 2010, The International journal of biological markers.

不同基因分型晚期非小细胞肺癌患者的预后分析

Quan Zhang, Shucai Zhang, Jinghui Wang, 2017, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Clinical Analysis of 107 NSCLC Patients Harboring KRAS Mutation].

Quan Zhang, Shucai Zhang, Jinghui Wang, 2016, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Prediction of Long-Term Survival Outcome by Lymph Node Ratio in Patients of Parotid Gland Cancer: A Retrospective study

Quan Zhang, Yan-feng Chen, Wen-Mei Jiang, 2022, Frontiers in Surgery.

Nivolumab-induced Thyroid Dysfunctions in Patients with Previously Treated Non-small Cell Lung Cancer

Quan Zhang, Shucai Zhang, Jinghui Wang, 2019, Interdisciplinary Sciences: Computational Life Sciences.

[A randomized trial of liposomal paclitaxel plus cisplatin as first-line therapy for advanced non-small cell lung cancer].

Quan Zhang, Shucai Zhang, Qunhui Wang, 2012, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.

Quan Zhang, Shucai Zhang, Zongde Zhang, 2015, Journal of cancer research and therapeutics.

The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer

Quan Zhang, D. Su, M. Jin, 2017, Scientific Reports.

盐酸埃克替尼一线治疗晚期肺腺癌的临床疗效观察

Quan Zhang, Shucai Zhang, Hui Zhang, 2013, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Comparison of EGFR signaling pathway somatic DNA mutations derived from peripheral blood and corresponding tumor tissue of patients with advanced non-small-cell lung cancer using liquidchip technology.

Quan Zhang, Shucai Zhang, Shanqing Li, 2013, The Journal of molecular diagnostics : JMD.

Crizotinib vs platinum‐based chemotherapy as first‐line treatment for advanced non‐small cell lung cancer with different ROS1 fusion variants

J. Ying, Junling Li, Yan Wang, 2020, Cancer medicine.

Subsequent treatment of epidermal growth factor receptor-tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma

W. Yue, Quan Zhang, Shucai Zhang, 2015, Thoracic cancer.

肺腺癌EGFR与KRAS基因突变状态分析

Quan Zhang, Shucai Zhang, Jinghui Wang, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Clinicopathologic characteristics of ALK rearrangements in primary lung adenocarcinoma with identified EGFR and KRAS status

Quan Zhang, Shucai Zhang, D. Su, 2014, Journal of Cancer Research and Clinical Oncology.

盐酸埃克替尼治疗EGFR突变状态明确的晚期非小细胞肺癌的临床观察

Quan Zhang, Shucai Zhang, Jinghui Wang, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

ERCC1基因多态性与晚期非小细胞肺癌患者铂类化疗疗效的关系

Quan Zhang, Shucai Zhang, Qunhui Wang, 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Application of ddPCR in detection of the status and abundance of EGFR T790M mutation in the plasma samples of non-small cell lung cancer patients

Y. Hu, Yan Wang, Quan Zhang, 2023, Frontiers in Oncology.

Dynamic cfDNA Analysis by NGS in EGFR T790M-Positive Advanced NSCLC Patients Failed to the First-Generation EGFR-TKIs

Mengjun Yu, Quan Zhang, Shucai Zhang, 2021, Frontiers in Oncology.

ALK阳性非小细胞肺癌脑转移患者的治疗

Quan Zhang, Shucai Zhang, Jinghui Wang, 2016, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

ALK-rearranged squamous cell lung cancer: a case report.

Quan Zhang, Shucai Zhang, Jinghui Wang, 2015, International journal of clinical and experimental pathology.

Crizotinib versus platinum‐based double‐agent chemotherapy as the first line treatment in advanced anaplastic lymphoma kinase‐positive lung adenocarcinoma

Quan Zhang, Shucai Zhang, Jinghui Wang, 2015, Thoracic cancer.

The hydrodynamics of low-density particles and optimization of the EMMS calculation process

Quan Zhang, Yue Qu, Xi Li, 2022, Powder Technology.

HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib

Quan Zhang, Shucai Zhang, Jinghui Wang, 2020, Frontiers in Oncology.

EGFR基因状态与晚期非小细胞肺癌患者一线化疗疗效的关系

Quan Zhang, Shucai Zhang, Jinghui Wang, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

PD-L1 Expression and Its Regulation in Lung Adenocarcinoma with ALK Translocation

Quan Zhang, Shucai Zhang, Jinghui Wang, 2019, Interdisciplinary Sciences: Computational Life Sciences.

驱动基因阳性且PD-L1高表达的非小细胞肺癌患者病理特征及靶向治疗疗效评估的真实世界研究

Quan Zhang, Shucai Zhang, Hui Zhang, 2021, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Nivolumab-induced Thyroid Dysfunctions in Patients with Previously Treated Non-small Cell Lung Cancer

Quan Zhang, Shucai Zhang, Jinghui Wang, 2019, Interdisciplinary Sciences Computational Life Sciences.

Efficacy and predictors of EGFR tyrosine kinase inhibitors in Chinese advanced lung adenocarcinoma: analyses of 253 cases from a single institute.

Quan Zhang, Shucai Zhang, Zongde Zhang, 2014, Oncology research.

[Clinical Value of Droplet Digital PCR and Super-ARMS Detection of Epidermal Growth Factor Receptor Gene Mutation in Plasma Circulating Tumor DNA of Patients with Advanced Lung Adenocarcinoma].

Quan Zhang, Shucai Zhang, Jing Wang, 2020, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

全脑放疗时间对EGFR突变非小细胞肺癌脑转移患者生存的影响

Quan Zhang, Shucai Zhang, Jinghui Wang, 2016, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Efficacy of Icotinib treatment in patients with stage IIIb/IV non‐small cell lung cancer

Quan Zhang, Shucai Zhang, Jinghui Wang, 2014, Thoracic cancer.

盐酸埃克替尼治疗晚期复发非小细胞肺癌的临床疗效

Quan Zhang, Shucai Zhang, Jinghui Wang, 2013, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

肺鳞癌EGFR与KRAS基因突变状态分析

Quan Zhang, Shucai Zhang, D. Su, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Clinical observation of icotinib hydrochloride for patients with advanced non-small cell lung cancer].

Quan Zhang, Shucai Zhang, Hui Zhang, 2012, Zhonghua zhong liu za zhi [Chinese journal of oncology].

SPECC1L-ALK: A novel gene fusion response to ALK inhibitors in non-small cell lung cancer.

Quan Zhang, Jinghui Wang, Yujie Dong, 2020, Lung cancer.

PD-L1 Expression and Its Regulation in Lung Adenocarcinoma with ALK Translocation

Quan Zhang, Shucai Zhang, Jinghui Wang, 2019, Interdisciplinary Sciences: Computational Life Sciences.

Efficacy and safety of iruplinalkib (WX‑0593) on non‑small cell lung cancer with SPECC1L‑ALK fusion: A case report

Quan Zhang, Shucai Zhang, Xi Li, 2023, Experimental and therapeutic medicine.